SEC Form 4 · accession 0001209191-15-034582
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geraldine Henwood
Director
Period of report
Apr 15, 2015
Accepted (ET)
Apr 16, 2015 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $39.07 | Apr 15, 2015 | A | 20,000 | A | — | Apr 14, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This option vests in equal quarterly installments over a three-year period beginning on July 15, 2015.